Pamela Blumenschein

Pamela Blumenschein is a genetic counsellor with Alberta Precision Laboratories and Alberta Health Services. She completed a Bachelor of Science Degree with a Specialization in Molecular Genetics at the University of Alberta in 2005 and a Master of Science in Genetic Counselling at Brandeis University in 2007. She currently works as a laboratory genetic counsellor and is cross appointed to the Medical Genetics Clinic where she practices in cancer genetics.

Selected Publications:

Secondary Reporting of G6PD Deficiency on Newborn Screening.
Hoang SC, Blumenschein P, Lilley M, Olshaski L, Bruce A, Wright NAM, Ridsdale R, Christian S.
Int J Neonatal Screen. 2023 Mar 27;9(2):18.

Sickle cell trait newborn screen results: disclosure and management.
Lilley M, Hoang S, Blumenschein P, Peturson AM, Sosova I, Macneil L, Ridsdale R, Christian S.
J Community Genet. 2021 Jan;12(1):137-142.

The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing.
Zhou JR, Ridsdale R, MacNeil L, Lilley M, Hoang S, Christian S, Blumenschein P, Wolan V, Bruce A, Singh G, Wright N, Parboosingh JS, Lamont RE, Sosova I.
Int J Neonatal Screen. 2021 Nov 16;7(4):78. 

Evaluating stakeholder’s perspectives on referred out genetic testing in Canada: a discrete choice experiment.
Blumenschein P, Lilley M, Bakal JA, Christian S.
Clin Genet. 2016;89(1)133-138

An assessment of Canadian systems for triaging referred out genetic testing.
Christian S, Blumenschein P, Lilley M.
Clin Genet. 2015;88(1)90-94

A centralized approach to out-of-province genetic testing leads to cost savings: the Alberta experience.
Lilley M, Christian S, Blumenschein P, Chan S, Somerville M.
Clin Genet. 2013;84(4):373-377